Application 209478

Type
NDA
Sponsor
CMP DEV LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CAROSPIRSPIRONOLACTONESUSPENSION;ORAL25MG/5MLYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
17856-0120CaroSpirCaroSpirATLANTIC BIOLOGICALS CORP.NDACurrent
17856-0120CaroSpirCaroSpirATLANTIC BIOLOGICALS CORP.NDACurrent
17856-0120CaroSpirCaroSpirATLANTIC BIOLOGICALS CORP.NDACurrent
46287-020CaroSpirCaroSpirCMP Pharma, Inc.NDACurrent
46287-020CaroSpirCaroSpirCMP Pharma, Inc.NDACurrent
46287-020CaroSpirCaroSpirCMP Pharma, Inc.NDACurrent
46287-020CaroSpirCaroSpirCMP Pharma, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
75316SUPPL 2023-08-29
75294SUPPL 2023-08-25
68559SUPPL2021-09-08
68557SUPPL2021-09-08
67961SUPPL2021-06-29
67928SUPPL2021-06-28
53642ORIG2018-04-10
49404ORIG2017-08-15
49268ORIG2017-08-08